A review of research on smoking cessation interventions for adults with schizophrenia spectrum disorders

Mental Health and Substance Use: Dual Diagnosis

Volumn 2, Issue 1, 2009, Pages 64-79

  Ferron, Joelle C ^a   Alterman, Arthur I ^b   McHugo, Greg J ^a   Brunette, Mary F ^a   Drake, Robert E ^a  

^a DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Bupropion; Nicotine replacement therapy; Psychosocial interventions; Schizophrenia; Severe mental illness; Smoking cessation

Indexed keywords

AMFEBUTAMONE; NICOTINE; NICOTINE GUM; NICOTINE PATCH;

ADULT; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RECURRENCE RISK; RELAPSE; REVIEW; SCHIZOPHRENIA; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 67651204387     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523280802593327     Document Type: Review

References (40)

1. Addington, J., El-Guelbaly, N., Campbell, W., Hodgins, D., & Addington, D. (1998). Smoking cessation treatment for patients with schizophrenia. American Journal of Psychiatry, 155, 974-976.
2. Barnes, M., Lawford, B.R., Burton, S.C., Heslop, K.R., Noble, E.P., Hausdorf, K., et al. (2006). Smoking and schizophrenia: Is symptom profile related to smoking and which antipsychotic medication is of benefit in reducing cigarette use? Australian and New Zealand Journal of Psychiatry, 40, 575-580.
3. Breckenridge, J.S. (1990). Smoking by outpatients. Hospital and Community Psychiatry, 41, 454-455.
4. Brown, S., Inskip, H., & Barraclough, B. (2000). Causes of the excess mortality of schizophrenia. British Journal of Psychiatry, 177, 212-217.
5. Centers for Disease Control and Prevention (CDC) (2004). The health consequences of smoking. Atlanta, GA: Surgeon General.
6. Chou, K., Chen, R., Lee, J., Ku, C., & Lu, R. (2004). The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia. International Journal of Nursing Studies, 41, 321-330.
7. Cohen, J. (1988). Statistical power analysis for the behavioral sciences. Hillsdale, NJ: Lawrence Earlbaum Associates.
8. Colton, C., & Manderscheid, R. (2006). Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Preventing Chronic Illness, 3, 1-14.
9. Cooke, F., Bullen, C., Whittaker, R., McRobbie, H., Chen, M., & Walker, N. (2008). Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine and Tobacco Research, 10, 607-612.
10. Currie, S.R., Karltyn, J., Lussier, D., de Denus, E., Brown, D., & El-Guelbaly, N. (2008). Outcome from a community-based smoking cessation program for persons with serious mental illness. Community Mental Health Journal, 44, 187-194.
11. Davidson, S., Judd, F., Jolley, D., Hocking, B., Thompson, S., & Hyland, B. (2001). Cardiovascular risk factors for people with mental illness. Australian and New Zealand Journal of Psychiatry, 35, 196-202.
12. de Leon, J., Dadvand, M., Canuso, C., White, A.O., Stanilla, J.K., & Simpson, G.M. (1995). Schizophrenia and smoking: An epidemiological survey in a state hospital. American Journal of Psychiatry, 152, 453-455.
13. de Leon, J., & Diaz, F.J. (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophrenia Research, 76, 135-157.
14. de Leon, J., Diaz, F.J., Rogers, T., Browne, D., & Dinsmore, L. (2002a). Initiation of daily smoking and nicotine dependence in schizophrenia and mood disorders. Schizophrenia Research, 56, 47-54.
15. de Leon, J., Tracy, J., McCann, E., McGrory, A., & Diaz, F.J. (2002b). Schizophrenia and tobacco smoking: A replication study in another US psychiatric hospital. Schizophrenia Research, 56, 55-65.
16. Etter, M., Mohr, S., Garin, C., & Etter, J.-F. (2004). Stages of change in smokers with schizophrenia or schizoaffective disorder and in the general population. Schizophrenia Bulletin, 30, 459-468.
17. Evins, A.E., Cather, C., Culhane, M.A., Birnbaum, A., Horowitz, J., Hsieh, E., et al. (2007). A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia. Journal of Clinical Psychopharmacology, 27, 380-386.
18. Evins, A.E., Cather, C., Deckersbach, T., Freudenreich, O., Culhane, M.A., Olm-Shipman, C.M., et al. (2005). A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia. Journal of Clinical Psychopharmacology, 25, 218-225.
19. Evins, A.E., Mays, V.K., Rigotti, N.A., Tisdale, T., Cather, C., & Goff, D.C. (2001). A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine and Tobacco Research, 3, 397-403.
20. Freeman, D.H. (1987). Applied categorical data analysis (Vol. 79). New York, NY: Marcel Dekker.
21. Gallagher, S.M., Penne, P.E., Schindler, E., & Layne, W. (2007). A comparison of smoking cessation treatments for persons with schizophrenia and other serious mental illnesses. Journal of Psychoactive Drugs, 39, 487-497.
22. George, T.P., Vessicchio, J.C., Sacco, K.A., Weinberger, A.H., Dudas, M.M., Allen, T.M., et al. (2008). A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry, 63, 1092-1096.
23. George, T.P., Vessicchio, J.C., Termine, A., Bregartner, T.A., Feingold, A., Rounsaville, B.J., et al. (2002). A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry, 52, 53-61.
24. George, T.P., Ziedonis, D.M., Feingold, A., Pepper, W.T., Satterburg, C.A., Winkel, J., et al. (2000). Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. American Journal of Psychiatry, 157, 1835-1842.
25. Glassman, A.H. (1993). Cigarette smoking: Implications for psychiatric illness. American Journal of Psychiatry, 150, 546-553.
26. Goff, D.C., Henderson, D.C., & Amico, E. (1992). Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. American Journal of Psychiatry, 149, 1189-1194.
27. Hughes, J.R., Hatsukami, D.K., Mitchell, J.E., & Dahlgren, L.A. (1986). Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143, 993-997.
28. Javors, M.A., Hatch, J.P., & Lamb, R.J. (2005). Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction, 100, 159-167.
29. Jorenby, D.E., Hays, J.T., Rigotti, N.A., Azoulay, S., Watsky, E.J., Williams, K.E., et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 56-63.
30. Lucksted, A., McGuire, C., Postrado, L., Kreyenbuhl, J., & Dixon, L. (2004). Specifying cigarette smoking and quitting among people with serious mental illness. The American Journal on Addictions, 13, 128-138.
31. McMurry, T.B. (2006). A comparison of pharmacological tobacco cessation relapse rates. Journal of Community Health Nursing, 23, 15-28.
32. Parker, D.R., Lasater, T.M., Windsor, R., Wilkins, J., Upegui, D.I., & Heimdal, J. (2002). The accuracy of self-reported smoking status assessed by cotinine test strips. Nicotine and Tobacco Research, 4, 305-309.
33. Perry, P.J., Miller, D.D., Arndt, S.V., Smith, D., & Holman, T. (1993). Haloperidol dosing requirements: The contribution of smoking and nonlinear pharmokinetics. Journal of Clinical Psychopharmacology, 13, 46-51.
34. Prochaska, J.J., Hall, S.M., & Bero, L.A. (2008). Tobacco use among individuals with schizophrenia: What role has the tobacco industry played? Schizophrenia Bulletin, 34, 555-567.
35. Steinberg, M., Ziedonis, D., Krejci, J., & Brandon, T. (2004). Motivational interviewing with personalized feedback: A brief intervention for motivating smokers with schizophrenia to seek treatment for tobacco dependence. Journal of Consulting and Clinical Psychology, 72, 723-728.
36. Thorndike, A.N., Stafford, R.S., & Rigotti, N.A. (2001). U.S. physicians' treatment of smoking in outpatients with psychiatric diagnoses. Nicotine and Tobacco Research, 3, 85-91.
37. Viswesvaran, C., & Schmidt, F.L. (1992). A meta-analytic comparison of the effectiveness of smoking cessation methods. Journal of Applied Psychology, 77, 554-561.
38. Weiner, E., Ball, M.P., Summerfelt, A., Gold, J., & Buchanan, R.W. (2001). Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. American Journal of Psychiatry, 158, 635-637.
39. Ziedonis, D.M., & George, T.P. (1997). Schizophrenia and nicotine use: Report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin, 23, 247-254.
40. Ziedonis, D.M., Kosten, T.R., Glazer, W.M., & Frances, R.J. (1994). Nicotine dependence and schizophrenia. Hospital and Community Psychiatry, 45, 204-206.